Alvotech fundraises $300m to bolster biosimilar development
Alvotech raised $300m through a private bond offering and is set to use the earnings to continue the growth of its biosimilar pipeline.
Alvotech raised $300m through a private bond offering and is set to use the earnings to continue the growth of its biosimilar pipeline.
Gene synthesis provider, GenScript, launched its new purification instrument, AmMag SA, to simplify purification processes and reduce time invested.
Celgene and Kyn Therapeutics enter a licensing agreement to develop Kyn’s immuno-oncology pipeline for investigative therapies after Celgene was acquired by BMS.